Fluticasone Furoate And Vilanterol has 5 known drug interactions based on U.S. FDA drug labeling data. 2 are classified as major interactions requiring close medical supervision. Notable interactions include combinations with Monoamine Oxidase Inhibitors (Maois), Nonselective Beta-Adrenergic Antagonists, Andthiazide. Patients taking Fluticasone Furoate And Vilanterol should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 5
- Major
- 2
- Moderate
- 3
Major (2)
- Fluticasone Furoate And Vilanterol + Monoamine Oxidase Inhibitors (Maois)— May potentiate effect of vilanterol on cardiovascular system, with increased risk of cardiovascular adverse effects.
- Fluticasone Furoate And Vilanterol + Nonselective Beta-Adrenergic Antagonists— May block bronchodilatory effects of vilanterol and produce severe bronchospasm in patients with COPD or asthma.
Moderate (3)
- Fluticasone Furoate And Vilanterol + Andthiazide— Electrocardiographic changes and hypokalemia may be worsened by vilanterol, especially at higher doses.
- Fluticasone Furoate And Vilanterol + Ketoconazole— 7 DRUG INTERACTIONS • Strong cytochrome P450 3A4 inhibitors (e.g., ketoconazole): Use with caution. Concomitant administ…
- Fluticasone Furoate And Vilanterol + Loop Diuretics— Electrocardiographic changes and hypokalemia may be worsened by vilanterol, especially at higher doses.